Trial Profile
Optimization of Darunavir Therapy Through Population Pharmacokinetic Modeling, Simulations and Dosage Guidelines
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Cobicistat/darunavir (Primary) ; Darunavir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 22 Jul 2020 Results of population pharmacokinetics model and simulation analysis based on exploration of reduced doses and frequency published in the Clinical Pharmacokinetics
- 30 Aug 2019 Status changed from active, no longer recruiting to completed.
- 17 Apr 2019 Planned End Date changed from 1 Mar 2019 to 1 Jul 2019.